Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Identifying Anxiety Symptoms in Multiple Sclerosis

Arch Phys Med Rehab; ePub 2018 Jun 30; Hughes, et al

The Generalized Anxiety Disorder Scale (GAD-2) is a clinically useful and psychometrically valid tool for screening anxiety symptoms in multiple sclerosis (MS) rehabilitation and neurology care settings, according to a recent study. Importantly, this tool has the potential to identify individuals with MS who are at risk for anxiety disorders and who may benefit from rehabilitation psychology interventions to ultimately improve functioning and quality of life. The sample was comprised of 99 adults (aged 19-72; M=46.2; SD=13.0; 75% female) with a physician-confirmed MS diagnosis who were receiving care in a university-affiliated MS center. Disease durations ranged from 1-37 years (M=10.7; SD=8.4). Participants completed the GAD-7 and GAD-2. Internal consistency was calculated for both measures. Researchers found:

  • Internal consistency was excellent for the GAD-7 (Cronbach α=.91) and acceptable for the GAD-2 (α=.77), and the measures were highly correlated (r=.94).
  • The GAD-2 had excellent overall accuracy for identifying clinically significant anxiety symptoms.
  • A GAD-2 cut-off score of ≥3 provided an optimal balance of good sensitivity (0.87) and excellent specificity (0.92) for detecting clinically significant anxiety symptoms.
  • Alternatively, a cut-off score of ≥2 provided excellent sensitivity (1.00) and fair specificity (0.76).

Citation:

Hughes AJ, Dunn KM, Chaffee T, Bhattarai J, Beier M. Diagnostic and clinical utility of the GAD-2 for screening anxiety symptoms in individuals with multiple sclerosis. [Published online ahead of print June 30, 2018]. Arch Phys Med Rehab. doi:10.1016/j.apmr.2018.05.029.

This Week's Must Reads

Behavioral Activation May Cut Dementia Disparity, JAMA Neurology; ePub 2018 Sep 10; Rovner, et al

GFAP: Marker of Brain Injury in Acute Mild TBI , Neurology; ePub 2018 Sept 12; Gill, Latour, et al

Study Identifies Acute Ischemic Stroke Risk Factors, J Stroke Cerebrovasc Dis; ePub 2018 Sep 8; Kim, et al

Deployment-Related TBI and Back Pain in Veterans, J Pain; ePub 2018 Aug 30; Suri, Stolzmann, et al

Treatment Outcomes Post-Surgery for Moyamoya Disease, J Neurol; ePub 2018 Sep 8; Kahn, Kaur, Stein, et al

Must Reads in Multiple Sclerosis

Pediatric Onset MS Linked with Reduced Parental QOL, Mult Scler; ePub 2018 Aug 30; O’Mahony, et al

Depressive Symptoms Negatively Impact on MS, J Neuropsychiatry Clin Neurosci; ePub 2018 Sep 6; Gill, et al

Evaluation of the MULES Picture Naming Test, J Neurol Sci; ePub 2018 Aug 23; Seay, Akhand, et al

Postrelapse Rehabilitation Use in MS Examined , Int J MS Care; ePub 2018 Sep 5; Asano, Eitzen, et al

Thalamic White Matter in Patients with MS, Hum Brain Mapp; 2018 Oct; Bergsland, et al